Skip Navigation


Rheumatology Advance Access originally published online on July 14, 2008
Rheumatology 2008 47(9):1406-1408; doi:10.1093/rheumatology/ken258
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
47/9/1406    most recent
ken258v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (2)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Schmidt, W. A.
Right arrow Articles by Krause, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schmidt, W. A.
Right arrow Articles by Krause, A.
Related Collections
Right arrow Vasculitis
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2008. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Prognosis of large-vessel giant cell arteritis

W. A. Schmidt1, A. Moll1, A. Seifert1, B. Schicke2, E. Gromnica-Ihle1 and A. Krause1

1Medical Centre for Rheumatology Berlin-Buch and 2Department of Statistics, Berlin Tumour Centre, Berlin, Germany.

Correspondence to: W. A. Schmidt, Medical Centre for Rheumatology Berlin-Buch, Karower Str. 11, 13125 Berlin, Germany. E-mail: schmidt.wa{at}t-online.de


   Abstract

Objective. The prognosis of large-vessel GCA (LV-GCA) has not yet been investigated. How does it compare to GCA without arm vasculitis (GCA controls)?

Methods. Charts of 53 LV-GCA patients and 53 GCA controls were reviewed following a predetermined protocol. Telephone interviews of patients or their primary care physicians were conducted. Forty LV-GCA patients underwent follow-up duplex ultrasound examinations of proximal arm arteries.

Results. The mean observation time was 50 (S.D. ± 31) months. None of the LV-GCA patients developed ischaemic arm complications. In 30%, proximal arm artery wall swelling disappeared completely. It decreased in 53%. In 8% it remained unchanged, in 5% it increased and in 5% arteries occluded with collateral flow. After the start of treatment, anterior ischaemic optic neuropathy developed neither in LV-GCA patients nor in GCA controls, amaurosis fugax occurred in 4 and 6%, arterial hypertension in 53 and 66%, strokes in 9 and 9%, myocardial infarction in 2 and 2%, diabetes mellitus in 30 and 25%, osteoporosis in 38 and 23%, and osteoporotic fractures in 15 and 4%, respectively. Mean corticosteroid dose was 3.7 mg/day. Mean duration of therapy was 42 months. All differences were insignificant. Four LV-GCA patients developed vasculitic popliteal artery stenoses.

Conclusions. The prognosis of LV-GCA is benign with regard to ischaemic complications. Proximal artery wall swelling decreases in most cases. Its course is similar to GCA without proximal arm arteritis.

KEY WORDS: Giant cell arteritis, Ultrasonography, Colour Doppler ultrasonography, Follow-up studies

Submitted 10 February 2008; revised version accepted 13 June 2008.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Rheumatology (Oxford)Home page
W. A. Schmidt, A. Krause, B. Schicke, J. Kuchenbecker, and E. Gromnica-Ihle
Do temporal artery duplex ultrasound findings correlate with ophthalmic complications in giant cell arteritis?
Rheumatology, April 1, 2009; 48(4): 383 - 385.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.